Structural features underlying raloxifene's biophysical interaction with bone matrix.

[1]  C. Rey,et al.  Infrared, Raman and NMR investigations of risedronate adsorption on nanocrystalline apatites. , 2014, Journal of colloid and interface science.

[2]  Joseph M. Wallace,et al.  Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties. , 2014, Bone.

[3]  Zhiyong Wang,et al.  Sulfuric Acid Intercalated Graphite Oxide for Graphene Preparation , 2013, Scientific Reports.

[4]  Joseph M. Wallace,et al.  In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs. , 2013, Bone.

[5]  M. Noventa,et al.  Update on Raloxifene: Mechanism of Action, Clinical Efficacy, Adverse Effects, and Contraindications , 2013, Obstetrical & gynecological survey.

[6]  J. Crockett,et al.  Osteoporosis – a current view of pharmacological prevention and treatment , 2013, Drug design, development and therapy.

[7]  V. Belgamwar,et al.  Solubility Enhancement of Raloxifene Using Inclusion Complexes and Cogrinding Method , 2013, Journal of pharmaceutics.

[8]  K. S. Hui,et al.  Synthesis, band-gap tuning, structural and optical investigations of Mg doped ZnO nanowires , 2012 .

[9]  Carneiro Al,et al.  Estrogens plus raloxifene on endometrial safety and menopausal symptoms--semisystematic review. , 2012 .

[10]  Deepak Kumar Khajuria,et al.  Medicamentos para o tratamento da osteoporose: revisão , 2011 .

[11]  W. Jahnke,et al.  An in vitro Assay to Measure Targeted Drug Delivery to Bone Mineral , 2010, ChemMedChem.

[12]  Jose R. Caeiro Rey,et al.  Raloxifene: Mechanism of Action, Effects on Bone Tissue, and Applicability in Clinical Traumatology Practice , 2009, The open orthopaedics journal.

[13]  H. Chao,et al.  Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. , 2008, Maturitas.

[14]  D. Burr,et al.  Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone. , 2007, Endocrinology.

[15]  D. Burr,et al.  Raloxifene enhances vertebral mechanical properties independent of bone density. , 2006, Bone.

[16]  Kaiyong Cai,et al.  Surface functionalized titanium thin films: zeta-potential, protein adsorption and cell proliferation. , 2006, Colloids and surfaces. B, Biointerfaces.

[17]  S. Martino,et al.  Safety assessment of raloxifene over eight years in a clinical trial setting* , 2005, Current medical research and opinion.

[18]  A. Shibata,et al.  Biophysic evaluation of bone quality-application of Fourier transform infrared spectroscopy and phosphorus-31 solid-state nuclear magnetic resonance spectroscopy. , 2004, The journal of medical investigation : JMI.

[19]  F. Cosman.  Selective estrogen-receptor modulators. , 2003, Clinics in geriatric medicine.

[20]  B. L. Riggs,et al.  Bone Turnover Matters: The Raloxifene Treatment Paradox of Dramatic Decreases in Vertebral Fractures Without Commensurate Increases in Bone Density , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  D. Black,et al.  Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  Y. Dufrêne,et al.  Influence of substratum surface properties on the organization of adsorbed collagen films: In situ characterization by atomic force microscopy , 1999 .

[23]  C. D. Jones,et al.  Molecular determinants of tissue selectivity in estrogen receptor modulators. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H W Cole,et al.  Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene. , 1997, Journal of medicinal chemistry.

[25]  F. G. Carpenter,et al.  Methods of sieve analysis with particular reference to bone char , 1950 .

[26]  D. Mahapatra,et al.  Drugs for the management of osteoporosis: a review. , 2011, Revista brasileira de reumatologia.

[27]  H. Bryant,et al.  Mechanism of action and preclinical profile of raloxifene, a selective estrogen receptor modulation. , 2001, Reviews in endocrine & metabolic disorders.

[28]  I. Rehman,et al.  Characterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy , 1997, Journal of materials science. Materials in medicine.